PT. RIDDHISEL GRAFTERAPI INDONESIA is a Company International Medical Technology
Biological graft industry passion on fulfilling “medical gap in biomaterial and medicine” which is unavailable in the market.
Follow the standard for FDA approval.
Decades of works, novel in product and methods.
Our platform : To regenerate damage tissue/organs using cell therapy based on personalized and targeting medicine.
Until recently our clinical studies are including the :
- SKIN ARTIFICIAL
- WOMB-LINE ENGINEERING - WOMB PATCH
- HEART ENGINEERING - HEART PATCH
Our Vision
To be a global leader in regenerative
therapies, transforming the future of
healthcare through innovative solutions that
promote healing and improve the quality of
life.
Our Mission
Developing biological matrix grafts and cell therapy
To generate high quality biological matrices
Using scaffold-based cell therapy, personalized-targeted for therapeutic and aesthetics.
To provide cells
Personalized-targeted for therapy and aesthetics.
© 2023. All rights reserved | PT. RIDDHISEL GRAFTERAPI INDONESIA